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Summary
Unlike histone H3, which is present only in S phase, the
variant histone H3.3 is expressed throughout the cell cycle
[1] and is incorporated into chromatin independent of repli-
cation [2]. Recently, H3.3 has been implicated in the cellular
response to ultraviolet (UV) light [3]. Here, we show that
chicken DT40 cells completely lacking H3.3 are hypersensi-
tive to UV light, a defect that epistasis analysis suggests
may result from less-effective nucleotide excision repair. Un-
expectedly, H3.3-deficient cells also exhibit a substantial
defect in maintaining replication fork progression on UV-
damaged DNA, which is independent of nucleotide excision
repair, demonstrating a clear requirement for H3.3 during S
phase. Both the UV hypersensitivity and replication fork
slowing are reversed by expression of H3.3 and require the
specific residues in the a2 helix that are responsible for
H3.3 binding its dedicated chaperones. However, expres-
sion of an H3.3 mutant in which serine 31 is replaced with
alanine, the equivalent residue in H3.2, restores normal
fork progression but not UV resistance, suggesting that
H3.3[S31A] may be incorporated at UV-damaged forks but
is unable to help cells tolerate UV lesions. Similar behavior
was observed with expression of H3.3 carrying mutations
at K27 and G34, which have been reported in pediatric brain
cancers. We speculate that incorporation of H3.3 during
replication may mark sites of lesion bypass and, possibly
through an as-yet-unidentified function of the N-terminal
tail, facilitate subsequent processing of the damage.Results and Discussion
H3.3-Deficient DT40Cells Are Viable but Exhibit Alterations
in Gene Expression
H3.3 is incorporated throughout the cell cycle [2, 4], parti-
cularly in regions of the genome in which histones need to
be displaced, such as transcribed genes or regulatory ele-
ments [5, 6]. Incorporation in these contexts depends on the
histone chaperone HIRA [7] and helps maintain chromatin
structure by filling gaps left by loss of H3.1/H4 [5, 8]. H3.3
deposition at transcriptionally active loci has also been pro-
posed to helpmaintain active expression, possibly by creating
a more accessible chromatin structure [2, 9]. However, H3.3 is
also incorporated in some repressed loci and at telomeres and
pericentric heterochromatin, where deposition depends on2Present address: The Gurdon Institute, Tennis Court Road, Cambridge
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creativecommons.org/licenses/by/3.0/).the ATRX-DAXX chaperone complex [10–12]. Although H3.3
is not essential for transcription in Drosophila, its loss results
in significantly decreased fertility and reduced viability during
embryogenesis [13]. Mouse embryonic stem cells with no
H3.3B and depleted of H3.3A exhibit altered regulation of pol-
ycomb-dependent gene expression that interferes with their
ability to differentiate [14]. Mice lacking H3.3B exhibit a semi-
lethal phenotype with reduced growth, anaphase bridging,
and karyotypic abnormalities [15]. Recently, H3.3 has also
been implicated in the response to ultraviolet (UV) irradiation,
because its chaperone HIRA is required to promote transcrip-
tion restart after UV damage [3].
In order to examine the effect of complete loss of H3.3 in a
differentiated vertebrate cell line, we created an H3.3 null
variant of the chicken bursal lymphoma DT40 [16]. In chicken,
as inmammals, H3.3 is encoded by two loci,H3.3A on chromo-
some 18 and H3.3B on chromosome 3. Despite considerable
divergence of the cDNA sequence of H3.3A and H3.3B, they
encode identical proteins, which also have the same sequence
as human H3.3. RNA deep-sequencing analysis (RNA-seq) of
DT40 revealed that H3.3B contributes over 90% of the total
pool of H3.3 transcript in chicken DT40 B cells (Figure 1A).
To create H3.3 null DT40 cells, we first disrupted both alleles
of H3.3B by homologous recombination using a targeting
strategy that removed the majority of the coding sequence
(Figure 1B; Supplemental Experimental Procedures available
online). This resulted in a substantial reduction of total H3.3
protein levels (Figure 1C), as predicted by the RNA-seq data
(Figure 1A). We then disrupted both alleles of H3.3A by
removing the whole H3.3A coding sequence (Figure 1B). This
resulted in loss of the remaining H3.3 protein (Figure 1C). We
subsequently refer to this H3.3 null line as h3.3DT40. h3.3 cells
proliferate more slowly than wild-type (c. 15 versus c. 11 hr;
Figure 1D). Their unperturbed cell-cycle profile suggests that
this is at least in part explained by an increase in spontaneous
apoptosis (Figure 1E).
We next examined the extent of transcriptional dysregula-
tion in cells lacking H3.3 by RNA-seq. This analysis revealed
that 557 of 16,396 gene transcripts (3.4%) exhibited a >2-fold
and significant (p < 0.001) change in expression (Figure 1F; Ta-
ble S1). Interestingly, the number of genes exhibiting a signif-
icant decrease in expression (235) is actually slightly exceeded
by those increasing in expression (324), supporting recent
evidence that H3.3, or its modifications, is not just important
for actively expressed loci [12, 14]. We observed no underlying
pattern to the chromosomal locations of affected genes (Fig-
ure S1). Thus, loss of H3.3 is linked to significant changes in
gene expression, but affects a relatively small fraction of loci
in DT40 cells.
H3.3 Is Likely to Operate in Concert with the Nucleotide
Excision Repair Pathway
In addition to being incorporated during transcription, recent
experiments have shown that H3.3 is deposited at sites of
UV-induced DNA damage by the histone chaperone HIRA,
where it facilitates the recovery of transcription after repair
of the damage [3]. We therefore asked whether h3.3 cells
exhibit sensitivity to UV light. h3.3 cells were modestly, but
Figure 1. DT40 Cells Deficient in H3.3
(A) Expression of H3.3 from the two alleles H3.3A and H3.3B, monitored by RNA-seq. The y axis represents the normalized number of reads from each locus.
(B) Gene targeting strategies for the H3.3A and H3.3B loci. Exons are shown as salmon pink boxes. The targeting arms are shown as gray boxes and the
selection cassette as a blue box. Primers are indicated in red and key restriction sites are in blue (endogenous) or red (introduced during cloning). See also
Supplemental Experimental Procedures.
(C) Confirmation of loss of H3.3 expression. Western blot of acid-extracted histones for H3.3 and total H3 from wild-type, cells lacking H3.3B (h3.3b), and
cells lacking both H3.3A and H3.3B (h3.3b/h3.3a; abbreviated h3.3).
(D) Growth of wild-type and h3.3 cells. Each point represents the average cell number for three experiments with error bars showing 1 SD. The lines are a
linear regression fit.
(E) One- and two-dimensional cell-cycle analysis of asynchronous populations of wild-type and h3.3 DT40. Each plot shows a total of 50,000 cells, and the
percentage of the total cycling cells in each gate is indicated. BrdU, bromodeoxyuridine.
(F) RNA-seq fromwild-type versus h3.3. The log2 expression level for each gene is determined from the normalized counts of three wild-type and three H3.3
RNA-seq experiments. Red dots represent genes whose expression differs by greater than 2-fold with p < 0.001.
See also Figure S1 and Table S1.
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This is unlikely to be a secondary effect, because no known
DNA damage response genes exhibited significantly dysre-
gulated expression in h3.3 cells (Table S1). Further, the
sensitivity of h3.3 cells to UV light was reversed by stable
expression of H3.3 C-terminally tagged with GFP (Figure 2A;
Figure S2). H3.2 could not substitute for H3.3 in rescuing the
UV sensitivity of h3.3. In fact, ectopic expression of H3.2 ap-
peared to cause further sensitization to UV, as previouslyobserved in yeast [17]. Because H3.3 has been implicated
in processes related to nucleotide excision repair (NER) [3],
we examined its genetic relationship to NER by performing
epistasis analysis of H3.3 with XPA, a key component of
the NER pathway. xpa DT40 cells are highly sensitive to UV
light, considerably more so than h3.3 (Figure 2B). A double
h3.3/xpa mutant was no more sensitive than xpa alone, sug-
gesting that XPA may be epistatic to H3.3 and that H3.3
acts to facilitate excision repair of a subset of UV lesions.
Figure 2. DNA Damage Sensitivity of H3.3-Deficient Cells
Colony survival assays following exposure to UV light.
(A) Complementation of the DNA damage sensitivity of h3.3 cells with H3.3 and H3.2. Two clones of the h3.3 knockout (c20 and c32) are shown. Fold sen-
sitivities versus wild-type: h3.3 c20 1.4; h3.3 c32 1.4; h3.3:H3.3-GFP 1; h3.3:H3.2-GFP 1.7.
(B) Epistasis of XPA to H3.3. That the colony survival assay has the power to detect additional sensitivity beyond that of the xpamutant is demonstrated by a
rev1/xpamutant, which lacks both NER and tolerance of UV lesions during replication by translesion synthesis. Fold sensitivities versus wild-type: h3.3 2.1;
xpa 17.5; h3.3/xpa 16.7; rev1 9; rev1/xpa 310.
(C) Alignment of chicken H3.2 and H3.3. The key differences are highlighted and the domain structure of the protein is indicated below the alignment.
(D) Complementation of h3.3 cells with H3.3 with a mutated chaperone-binding patch (abbreviated AIG>SVM) or S31A. Fold sensitivities versus wild-type:
h3.3 1.6; h3.3:H3.3[AIG>SVM] 1.7; h3.3:H3.3[S31A] 1.8.
(E) Effect of expression of H3.3 carrying a potentially phosphomimetic mutation of S31, S31D, or three nearby cancer-associated mutations, H3.3[K27M],
H3.3[G34R], and H3.3[G34V]. Fold sensitivities versus wild-type: h3.3 1.7; h3.3:H3.3[S31D] 1.8; h3.3:H3.3[K27M] 1.6; h3.3:H3.3[G34R] 1.6; h3.3:H3.3
[G34V] 1.5.
Survival assays were performed three times and 1 SD of the surviving fraction is indicated. For clarity, only the positive error bar is shown. See also Fig-
ure S2.
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namic range to detect additional sensitivity over and above
that of the xpa mutant (Figure 2B), the very large difference
in the sensitivities of the h3.3 and xpa mutants means that
epistasis in this instance must be interpreted with some
caution.
Resistance to DNA Damage Requires the H3.3-Specific
Chaperone-Binding Patch and S31
H3.3 differs at two sites from H3.2, the single canonical H3 in
chickens (Figure 2C). S31, in the N-terminal tail region and analanine in H3.2, has been reported to be phosphorylated dur-
ingmitosis, although the function of this modification is not yet
understood [18]. H3.3 also has three residues at the base of a
helix 2 that differ from H3.2. These are A87/I89/G90, which are
S87/V89/M90 in H3.2 (hereafter referred to as ‘‘AIG’’ and
‘‘SVM’’). This ‘‘patch’’ is thought to define the chaperone spec-
ificity of H3.2 and H3.3. Thus, the AIG patch is required for
binding of H3.3 to DAXX [10] and is required for replication-
independent chromatin deposition [2, 4], that is dependent
on HIRA [7]. We created h3.3 clones stably expressing H3.3-
GFP carrying either a substitution of the AIG patch with the
Figure 3. H3.3 Is Required to Maintain Replica-
tion Fork Progression after UV Exposure
(A) Schematic of the fork labeling experiment.
IdU, iododeoxyuridine; CldU, chlorodeoxyuri-
dine.
(B) Sample pictures of DNA fibers labeled from
h3.3 cells. The point of UV exposure is indicated
by the white arrowhead.
(C–E) Replication fork stalling of wild-type or mu-
tants in response to either sham irradiation (solid
lines) or 40 J/m2 265 nm UV light (dashed lines).
The ratio of the length of the second label to the
first is calculated for each fiber, and the data
are presented as a cumulative percentage of
forks at each IdU:CldU ratio. The p value that
the cumulative distribution with UV is different
from wild-type is shown (Kolmogorov-Smirnov
test). NS, not significant (i.e., p > 0.001).
See also Figure S3.
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matched expression levels by monitoring GFP by flow cytom-
etry (Figure S2). Neither the AIG patch nor S31A H3.3 mutants
complemented the UV hypersensitivity of h3.3 cells (Fig-
ure 2D), suggesting that the chaperone binding specificity of
H3.3 and a serine at position 31 are required. A potentially
phosphomimetic substitution of S31 with aspartic acid alsodid not complement the UV sensitivity
of h3.3 cells (H3.3[S31D]; Figure 2E).
Pediatric Cancer-Associated H3.3
Mutations near S31 Also Result in UV
Sensitivity
Recently, mutations in the N-terminal
tail of H3.3, in the vicinity of S31, have
been linked to a number of pediatric
cancers, including glioblastoma, chon-
droblastoma, and giant cell tumors of
bone [19–21]. Understanding the mech-
anistic basis for the clinical effects of
these apparently driver mutations has
focused on their effects on posttrans-
lational modifications of H3. Thus,
mutations at G34 affect the global distri-
bution of H3K36me3 and changes in
gene expression [22]. Likewise, muta-
tion of H3.3K27, a residue whose trime-
thylation is associated with polycomb
complex-mediated transcriptional re-
pression, results in reduced global
H3K27me3 and derepression of mult-
iple transcripts [23]. Because S31 lies
close to these residues, we wondered
whether the cancer-associated muta-
tions K27M, G34R, and G34V [19, 20]
might also confer sensitivity to DNA
damage. Interestingly, all three H3.3
mutants exhibit UV sensitivity similar to
the h3.3 knockout, suggesting that
these residues are also required for
the role played by H3.3 in facilitating
excision repair (Figure 2E). This some-
what surprising result suggests the
possibility that H3.3 cancer-associatedmutations could impact on DNA repair as well as on transcrip-
tional regulation, a point that merits further exploration.
H3.3 Is Required during S Phase to Maintain Processive
Replication after UV Irradiation
Histone supply affects the processivity of DNA replication
[24]. Although the deposition of H3.3 is primarily replication
Figure 4. Response of h3.3 Cells to Other Forms of DNA Damage
(A) Sensitivity of h3.3 cells to cisplatin. Fold sensitivities versus wild-type: h3.3 c20 2.5; h3.3 c32 2.8; h3.3:H3.3-GFP 1.4; h3.3:H3.2-GFP 4.1.
(B) Sensitivity of h3.3 cells to methyl methanesulfonate. Fold sensitivity versus wild-type: h3.3 1.4.
(C) Sensitivity of h3.3 cells to X-rays. Fold sensitivities versus wild-type: h3.3 c20 1.1; h3.3 c32 1.1.
(D) Sensitivity of h3.3 AIG patch and S31A mutants to cisplatin. Fold sensitivities versus wild-type: h3.3 2.3; h3.3:H3.3[AIG>SVM] 2.3; h3.3:H3.3
[S31A] 2.6.
(E) Sensitivity of h3.3 N-terminal tail mutants to cisplatin. Fold sensitivities versus wild-type: h3.3 2.2; h3.3:H3.3[S31D] 2.1; h3.3:H3.3[K27M] 1.9; h3.3:H3.3
[G34R] 2.7; h3.3:H3.3[G34V] 2.3. Survival assays were performed three times and 1 SD of the surviving fraction is indicated. For clarity, only the positive error
bar is shown.
(F) Replication fork stalling of wild-type or mutants in response to either sham treatment (solid lines) or 2.5 mM cisplatin (dashed lines).
(G) Replication fork stalling of wild-type or mutants in response to either sham treatment (solid lines) or 0.05% methyl methanesulfonate (dashed
lines). The p value that the cumulative distribution with UV is different from wild-type is shown (Kolmogorov-Smirnov test). NS, not significant (i.e.,
p > 0.001).
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replication by monitoring fork progression in stretched DNA
fibers. We pulse labeled cells sequentially with two different
halogenated nucleosides (iododeoxyuridine and chlorodeox-
yuridine; 20 min each), stretched the extracted DNA on glass
slides, and revealed the replicons with antibodies specific for
the halogenated nucleotides (Figure 3A). Loss of H3.3 did not
affect replication dynamics in unperturbed conditions. Weobserved a small, but not significant, decrease in median
fork velocity in h3.3 cells but no change in replication origin
density (Figures S3A–S3C). However, after UV irradiation,
applied at the same time as the second label, replication
fork progression in the second 20 min was dramatically
reduced in h3.3 cells in comparison to wild-type (Figures 3B
and 3C). It is likely that at least some of these forks remain
persistently blocked, because a greater fraction of h3.3 cells
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ing a delay in completion of replication (Figure S3D). The de-
layed fork progression following UV exposure in h3.3 cells
was reduced to wild-type levels by expression of H3.3-GFP
but not H3.2-GFP (Figure 3C). Although this defect is reminis-
cent of cells lacking the translesion polymerase REV1 [25, 26],
we could observe robust translesion synthesis of UV (6-4)
photoproducts in xpa/h3.3 cells using a replicating plasmid
assay [27] and, further, the frame infidelity characteristic of
photoproduct bypass in REV1-deficient cells [27] was not
evident (Figures S3E–S3G). Thus, delayed replication fork
progression after UV damage in h3.3 cells does not appear
to result from a significant defect in REV1-dependent transle-
sion DNA synthesis. We then asked whether the role of H3.3 at
the replication fork was also dependent on both the AIG patch
and S31, as for UV sensitivity. Whereas the AIG-to-SVM patch
mutant failed to complement the defective fork progression
after UV (Figure 3C), the H3.3[S31A] mutant restored wild-
type behavior (Figure 3C), as did the cancer-associated mu-
tants G34V, G34R, and K27M (Figure 3D). In view of the
apparent epistasis of H3.3 and XPA, we considered whether
the delayed fork progression in h3.3 cells reflected defective
excision repair. However, h3.3 cells exhibit a much more
prominent defect in fork progression after UV than xpa cells,
the response of which is similar to wild-type (Figure 3E).
This is not consistent with the fork progression defect seen
after UV in h3.3 cells resulting from defective NER at the
fork, an event that in any case would likely be deleterious to
cell survival due to strand incision at the lesion causing repli-
cation fork collapse.
Finally, we asked whether the role of H3.3 in the response to
UV was also seen with other forms of DNA damage. In addition
to UV, h3.3 cells exhibit mild hypersensitivity to the interstrand
crosslinking agent cisplatin and the alkylating agent methyl
methanesulfonate (MMS) but not to X-rays (Figures 4A–4C).
In the case of cisplatin, both the AIG patch and N-terminal
tail mutants discussed above exhibit hypersensitivity (Figures
4D and 4E), as observedwith UV. However, for neither cisplatin
norMMS is there any exacerbation of the delay in fork progres-
sion induced by these agents (Figures 4F and 4G), a point we
consider further below.
Our observations provide the first clear evidence of the
involvement of a variant histone in replication fork progres-
sion, and suggest that forks require a supply of H3.3 when
they encounter UV damage to maintain processive replica-
tion. Although our experiments are not able to show directly
that H3.3 is incorporated by the replication fork during repli-
cation of UV DNA damage, by analogy with the effect of his-
tone supply on bulk DNA replication [24], we suggest that the
defective fork progression in h3.3 cells is a result of failure of
a process that would normally see H3.3 incorporated. We
speculate that H3.3 incorporation during the replication of
UV lesions at the fork, and possibly during postreplicative
lesion bypass, may facilitate subsequent access and repair
(Figure S4). H3.3 incorporation would imply the need for an
H3.3-specific chaperone. HIRA would seem to be a strong
candidate given its documented role in H3.3 incorporation
at sites of UV damage [3], although the same study reported
that HeLa cells depleted for HIRA are not UV sensitive [3].
Whether ATRX plays any role in replicating UV-damaged
DNA is unknown, but it has been implicated in the replication
of G quadruplex DNA [28] and, recently, ATRX-deficient cells
have been shown to exhibit replication defects, suggesting
that it contributes to limiting fork stalling during S phase [29].Although cells lacking H3.3 are sensitive to UV, MMS, and
cisplatin, a fork progression defect, as assessed in labeled
DNA fibers, is only observed after UV exposure. This suggests
a broad requirement for H3.3 in facilitating DNA repair, but
that incorporation of this histone variant may not only take
place ‘‘on the fly’’ at the replication fork when it encounters
DNA damage but also, for instance, during lesion bypass in
postreplicative gaps. Loss of this latter role would not be
detectable as a defect in the DNA fiber assay. The basis for
this specificity remains unclear, but we speculate that it may
be related to the mechanisms and complexes cells bring
into play at different lesions, which in turn may affect the
timing of lesion bypass [30]. Indeed, such damage-dependent
specificity is now well documented in translesion synthesis
[31] and, recently, damage caused by UV and by MMS has
been shown to induce quite distinct bypass responses in hu-
man cells [32]. However, much further work is needed to
understand the contexts in which H3.3 is required for proces-
sive replication of damaged DNA.
Finally, how might H3.3 incorporation facilitate subsequent
DNA repair and survival? Because it has been proposed that
H3.3-containing chromatin has a more open and accessible
structure [9], its incorporation may be particularly important
for promoting NER in highly condensed regions of the
genome. Additionally, the damage sensitivity of the h3.3 cells
may also be related to its ability to promote transcriptional
recovery after repair [3], possibly through its ability to
interact specifically with components of the FACT chromatin
remodeling complex [12], which has itself been implicated in
transcriptional recovery after NER and in resistance to UV
damage [33].
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